(NYSE: CBT) Cabot's forecast annual revenue growth rate of 1.34% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Cabot's revenue in 2025 is $3,908,000,000.On average, 3 Wall Street analysts forecast CBT's revenue for 2025 to be $205,781,752,862, with the lowest CBT revenue forecast at $204,953,557,830, and the highest CBT revenue forecast at $206,555,042,904. On average, 3 Wall Street analysts forecast CBT's revenue for 2026 to be $212,251,086,397, with the lowest CBT revenue forecast at $210,809,373,768, and the highest CBT revenue forecast at $213,956,471,912.
In 2027, CBT is forecast to generate $218,480,492,647 in revenue, with the lowest revenue forecast at $215,483,281,902 and the highest revenue forecast at $222,398,517,017.